Latest Operating Expenses News

Page 3 of 60
Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.
Ada Torres
Ada Torres
25 Nov 2025
Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.
Ada Torres
Ada Torres
25 Nov 2025
Web Travel Group Limited reports robust half-year results for FY26, with its B2B travel division WebBeds fueling a 20% revenue increase despite rising costs and finance pressures.
Victor Sage
Victor Sage
25 Nov 2025
Wide Open Agriculture has received a $586,624 tax rebate for its overseas research activities in Germany, supporting the commercialisation of its proprietary lupin protein products.
Eva Park
Eva Park
24 Nov 2025
Maggie Beer Holdings has announced a $2.28 million entitlement offer priced at a 10.3% discount to raise working capital, inviting eligible shareholders to participate in a 1-for-10 share issue.
Victor Sage
Victor Sage
24 Nov 2025
ReadCloud Limited's FY25 results reveal a robust earnings surge driven by significant growth in Australian school-focused businesses, with underlying EBITDA more than doubling. The company signals continued momentum into FY26 amid strategic business reviews.
Victor Sage
Victor Sage
20 Nov 2025
ReadCloud Limited reported a robust FY25 with a 109% surge in underlying EBITDA, driven by strong growth in its Australian school businesses. The company’s FY26 outlook targets continued organic expansion and disciplined execution amid industry funding uncertainties.
Victor Sage
Victor Sage
20 Nov 2025
Apiam Animal Health reported a challenging FY25 with underperformance in its core clinical segment but has rebounded strongly in Q1 FY26. The company is now poised for acquisition by Adamantem Capital, offering shareholders a premium cash and scrip deal.
Ada Torres
Ada Torres
20 Nov 2025
AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.
Victor Sage
Victor Sage
20 Nov 2025
Clover Corporation Limited reported a standout FY25 with robust revenue growth and a sharp rise in profitability, underpinned by strategic market expansion and product innovation. The company’s strengthened balance sheet and optimistic FY26 outlook signal continued momentum.
Victor Sage
Victor Sage
18 Nov 2025
QuickFee Limited reports a pivotal FY25 with strong revenue growth and positive underlying profitability, alongside a strategic sale of its US Pay Now business and a proposed capital return to shareholders.
Claire Turing
Claire Turing
18 Nov 2025
Plenti Group Limited has reported a remarkable half-year performance for FY26, with revenues up 20% and profit soaring over tenfold to $10.5 million. The fintech lender’s loan portfolio expanded 24%, driven by strong demand across automotive, renewable energy, and personal loans.
Claire Turing
Claire Turing
18 Nov 2025